UPDATE from ROCHE clinical research program into HD drugs

ROCHE / GENENTECH have released a statement:

Update on tominersen (RG6042)* Huntington’s disease (HD) clinical programme: Recruitment into GENERATION HD1 clinical trial has been completed

You can read the statement in full here.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.